It could be demonstrated that C-188-9, a small molecule STAT3 inhibitor, which targets the phospho-Tyr705 peptide binding pocket, decreased experimental pulmonary fibrosis in mice, as shown by dimished α-SMA expression and reduced collagen deposition [20]. The gene discussed is STAT3; the disease is pulmonary fibrosis.